홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Idebenone

HCID 3686
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
58186-27-9
표준 SMILES
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
분자식
C19H30O5
평균 분자량
338.4 g/mol
단동위원소 질량
338.20932405

개요

Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as a ferroptosis inhibitor and an antioxidant. It is a member of 1,4-benzoquinones and a primary alcohol.

이름 및 식별자

우선 이름
Idebenone
IUPAC
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
영어명
Idebenone
분자식
C19H30O5
분자량
338.44

이름 및 동의어

idebenone58186-27-9IdebenonaRaxone2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dioneIdebenonumSovrimahydroxydecyl ubiquinoneCV 2619Oristar hdu2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinoneCV-2619
이름 더 보기
IdebenonAvandebenoneIdebenone powder6-(10-DarumaMnesisQSA-10
6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinoneDTXSID0040678HB6PN45W4JCHEBI:31687NSC-7592282-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone2,5-Cyclohexadiene-1,4-dione, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-DTXCID8020678

데이터베이스 식별자

CAS
58186-27-9
PubChem CID
3686
DTXSID
DTXSID0040678
ChEMBL
CHEMBL252556
ChEBI
CHEBI:31687
UNII
HB6PN45W4J
EC Number
814-253-7
Nikkaji
J22.706D

물성

구조 계산 물성보충 중

XLogP
4.3
극성 표면적
72.8 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
5
회전 가능 결합 수
12
무거운 원자 수
24
형식 전하
0
복잡도
502

실험 및 물리화학적 성질

CosmeticsCosmetic ingredients (Hydroxydecyl Ubiquinone) -> CIR (Cosmetic Ingredient Review)
LogP2.96
Human DrugsEMA approved medicines: Human medicine
Collision Cross Section · 2건

181.21 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

178.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
52 · 52-550C
끓는 점
497.3 · 497.3±45.0 °C(Predicted)
밀도
1.08 · 1.08±0.1 g/cm3(Predicted)
저장 조건
room temp
용해도
DMSO에 용해됩니다(최대 25mg/ml).
산도 계수 (pKa)
15.2 · 15.20±0.10(Predicted)
물리적 상태
Solid
색상
오렌지 레드
Merck
14 · 14,4888
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO 용액은 -20°C에서 최대 3개월 동안 보관할 수 있습니다.
화장품 원료 기능
항산화제
InChI
InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
SMILES
C1(=O)C(OC)=C(OC)C(=O)C(C)=C1CCCCCCCCCCO
LogP
3.49 · 3.490 (est)

화학적 성질

An odorless yellow-orange crystalline solid. It is highly insoluble in water, but can be easily dissolved in chloroform, methanol, or absolute ethanol. It is also soluble in ethyl acetate, but insoluble in n-hexane.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.

Danger

H228 (25%): Flammable solid [Danger Flammable solids]

P210, P240, P241, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesFlam. Sol. 2 (25%)

독성 정보

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

안전 데이터

wgk
3
rtecs
GU5290000
HS 번호
2933399990
hazard_code
Xi

화학 및 산업

약리 정보

ATC Code · 3건

N06BX13

N - Nervous system

QN - Nervous system

Mechanism of Action · 1건

Idebenone is a synthetic analogue of ubiquinone (also known as Coenzyme Q10), a vital cell antioxidant and essential component of the Electron Transport Chain (ETC). It has been proposed that by interacting with the ETC, idebenone increases ATP production required for mitochondrial function, reduces free radicals, inhibits lipid peroxidation, and consequently protects the lipid membrane and mitochondria from oxidative damage. More specifically, idebenone is thought to transfer electrons directly to complex III of the mitochondrial ETC, thereby circumventing complex I and restoring cellular energy (ATP) generation.

Metabolism/Metabolites · 1건

Metabolism occurs by means of oxidative shortening of the side chain and by reduction of the quinone ring and conjugation to glucuronides and sulphates. Idebenone shows a high first pass metabolism resulting in conjugates of idebenone (glucuronides and sulphates (IDE-C)) and the Phase I metabolites QS10, QS6, and QS4 as well as their corresponding Phase II metabolites (glucuronides and sulphates (QS10+QS10-C, QS6+QS6-C, QS4+QS4-C)). The main metabolites in plasma are IDE-C and QS4+QS4-C.

MeSH Pharmacological ClassificationNaturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Absorption, Distribution and Excretion · 3건

After oral administration, idebenone is rapidly absorbed. On repeat dosing, maximum plasma concentrations of idebenone are reached on average within 1 hour (median 0.67 h range: 0.33-2.00 h). Food increases the bioavailability of idebenone by approximately 5-7-fold and i therefore should always be administered with food.

The main route of elimination is metabolism, with the majority of dose excreted via the kidneys as metabolites. After a single or repeated oral dose of 750 mg of idebenone, QS4+QS4-C were the most prominent idebenone-derived metabolites in urine, representing on average between 49.3% and 68.3% of the total administered dose. QS6+QS6 represented 6.45% to 9.46%, whereas QS10+QS10-C and IDE+IDE-C were close to 1% or below.

Experimental data have shown that idebenone passes the blood-brain barrier and is distributed at significant concentrations in cerebral tissue. Following oral administration pharmacologically relevant concentrations of idebenone are detectable in the aqueous humor of the eye.

용도 및 제조

UsesCIR ingredient: Hydroxydecyl Ubiquinone
응용 분야 · 3건

개요Idebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function. However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.

용도idebenone is an anti-oxidant capable of protecting the skin from a variety of free-radical attacks, including the formation of secondary chemicals that negatively affect skin physiology. It is said to improve intrinsic as well as extrinsic skin damage caused by freeradical formation. Idebenone is a synthetically manufactured form of coenzyme Q10 and has a smaller molecular structure. This allows it to penetrate the skin and apparently the cellular membrane. Clinical studies demonstrate a visible improvement in photodamaged skin, reduced skin roughness and dryness, decreased fine lines and wrinkles, and increased skin hydration. In addition, idebenone helps improve hyperpigmentation because its molecular structure is similar to that of hydroquinone. Although most of the associated benefits are seen primarily in the epidermis, some increase in dermal collagen has also been confirmed. Idebenone has been used for such health-related problems as Alzheimer’s and heart disease.

일반 설명Idebenone is a short-chain benzoquinone drug. It is a structural relative of ubiquinone (Coenzyme Q10) that protects the CNS from the effects of ischemia via improving brain metabolism. It is reported to be of potential use in the management of patients with cerebral apoplexy, cerebral arteriosclerosis and related disorders.

상·하류 제품 정보

상류 원료

노르말헥산N,N-다이메틸폼아마이드크리소이딘10-acetoxycarbonyl chloride크레졸제일인산칼륨디클로로메탄3,4,5-Trimethoxytoluene

하류 제품

Idebenone Sulfate
추가 설명 · 1건

정의ChEBI: Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as an antioxidant and a ferroptosis inhibitor. It is a primary alcohol and a member of 1,4-benzoquinones.

관련 반응

38건
반응 기록 만들기
HRID 147968 반응식
HRID 147968반응물로
HRID 299093 반응식
HRID 299093생성물로
HRID 370412 반응식
HRID 370412반응물로
HRID 580246 반응식
HRID 580246반응물로
HRID 637893 반응식
HRID 637893생성물로
HRID 637894 반응식
HRID 637894생성물로
HRID 637895 반응식
HRID 637895생성물로
HRID 637896 반응식
HRID 637896생성물로
이전1 / 5 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트